Treatment with asciminib after a prior tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia

Authors:

Abstract
No abstract available
Funding Information
  • Novartis Pharmaceuticals Corporation

This publication has 27 references indexed in Scilit: